Esperion Therapeutics, Inc. - ESPR
About Gravity Analytica
Recent News
- 06.09.2025 - Goldman Sachs Global Healthcare Conference
- 06.09.2025 - Goldman Sachs Global Healthcare Conference
- 06.04.2025 - Jefferies Global Healthcare Conference
- 06.04.2025 - Jefferies Global Healthcare Conference
- 06.02.2025 - Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040
- 06.02.2025 - Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040
- 06.02.2025 - Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040
- 05.29.2025 - Esperion Therapeutics, Inc. 2025 Annual Meeting of Stockholders
- 05.29.2025 - Esperion Therapeutics, Inc. 2025 Annual Meeting of Stockholders
- 05.29.2025 - Esperion Therapeutics, Inc. 2025 Annual Meeting of Stockholders
Recent Filings
- 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.02.2025 - 8-K Current report
- 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.02.2025 - 4 Statement of changes in beneficial ownership of securities